Farima disease: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{CMG}}; {{AE}} {{SMP}} {{USAMA}} ==Overview== aKUYFILUEFGKJQWEF ==Pathophysiology== ierqhgierhgj *A *B **B1 **B2 # #") |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{CMG}}; {{AE}} {{SMP}} {{USAMA}} | {{CMG}}; {{AE}} {{SMP}} {{USAMA}} | ||
==Overview== | ==Overview== | ||
aKUYFILUEFGKJQWEF | aKUYFILUEFGKJQWEF | ||
=== '''classification''' === | |||
==Pathophysiology== | ==Pathophysiology== | ||
ierqhgierhgj | '''[[Furosemide|ierqhgierhgj]]''' | ||
A | |||
{| class="wikitable" | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
!Disease | |||
! | |||
!Signs | |||
! | |||
! | |||
|- | |||
! | |||
! | |||
! | |||
! | |||
! | |||
|- | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|} | |||
*B | *B | ||
**B1 | **B1 | ||
Latest revision as of 14:27, 24 October 2017
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Seyedmahdi Pahlavani, M.D. [2] Usama Talib, BSc, MD [3]
Overview
aKUYFILUEFGKJQWEF
classification
Pathophysiology
A
| Disease | Signs | |||
|---|---|---|---|---|
- B
- B1
- B2